●] Shares SCHRÖDINGER, INC. COMMON STOCK (PAR VALUE $0.01 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • January 27th, 2020 • Schrodinger, Inc. • Pharmaceutical preparations • New York
SCHRÖDINGER, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • January 27th, 2020 • Schrodinger, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 9th day of November, 2018, by and among Schrödinger, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes party to this Agreement in accordance with Section 6.9 hereof.
AMENDED AND RESTATED SHARE EXCHANGE AGREEMENTShare Exchange Agreement • January 27th, 2020 • Schrodinger, Inc. • Pharmaceutical preparations • Delaware
This Amended and Restated Share Exchange Agreement (this “Agreement”) by and between Schrödinger, Inc., a Delaware corporation (the “Company”), and the Bill & Melinda Gates Foundation Trust (the “Trust”) is dated as of the 24th day of January, 2020 and shall be effective as of the Charter Amendment Filing Date (as defined below).
Schrödinger, Inc. STOCK OPTION AGREEMENTStock Option Agreement • January 27th, 2020 • Schrodinger, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
